After booking a 95% combined ratio in 2022 and increasing run-rate premium to $3bn from $2.1bn in 2021, Core Specialty expects to grow by 18%-22% in 2023 as the company continues to capitalize on the current E&S boom and...
After booking a 95% combined ratio in 2022 and increasing run-rate premium to $3bn from $2.1bn in 2021, Core Specialty expects to grow by 18%-22% in 2023 as the company continues to capitalize on the current E&S boom and...